financetom
Business
financetom
/
Business
/
China's Bilibili launches $575 million convertible notes offering
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
China's Bilibili launches $575 million convertible notes offering
May 26, 2025 12:03 PM

(Reuters) -China's online video-sharing platform Bilibili ( BILI ) said on Wednesday it is offering up to $575 million worth of convertible notes to raise money to develop its content ecosystem.

The company said the offering will include $500 million of convertible senior notes due 2030, with an option to purchase a further $75 million worth.

The funds will facilitate user growth, building intellectual property and also fund the repurchase of some of class Z shares, Bilibili ( BILI ) said.

Goldman Sachs, Morgan Stanley, JP Morgan and UBS are acting as the joint bookrunners for the senior notes offering.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Spotify Technology Signs Multi-Year Recorded Music, Music Publishing Deals With Universal Music Group
Spotify Technology Signs Multi-Year Recorded Music, Music Publishing Deals With Universal Music Group
Jan 27, 2025
04:50 AM EST, 01/27/2025 (MT Newswires) -- Spotify Technology ( SPOT ) and Universal Music Group said Sunday that they signed new, multi-year agreements to collaborate on recorded music and music publishing. The companies said their collaboration aims to advance streaming innovation and feature new offers, subscription tiers, music bundles, and non-music content. The agreements also cover a direct license...
Sarepta Therapeutics Says Phase 3 Study of Potential Muscular Dystrophy Drug Shows 'Positive' Results
Sarepta Therapeutics Says Phase 3 Study of Potential Muscular Dystrophy Drug Shows 'Positive' Results
Jan 27, 2025
04:28 AM EST, 01/27/2025 (MT Newswires) -- Sarepta Therapeutics ( SRPT ) said Monday that the second part of a phase 3 clinical study of the gene therapy Elevidys for the potential treatment of Duchenne muscular dystrophy has yielded positive topline results. Patients treated with a placebo in the first part of the study but began receiving the drug, also...
Johnson Matthey to review executive pay, cut spend in hydrogen technologies
Johnson Matthey to review executive pay, cut spend in hydrogen technologies
Jan 27, 2025
* JMAT aims for higher cash conversion levels by 2026 * Steps follow pressure from top investor Standard Investments (Adds details on review in paragraphs 4, 10 and 11, share move in paragraph 7, sector context in paragraph 12) Jan 27 (Reuters) - British autocatalyst maker Johnson Matthey ( JMPLF ) said on Monday it would review its executive pay...
US Steel Investor Ancora Reportedly Seeks End of Nippon Merger, CEO Replacement
US Steel Investor Ancora Reportedly Seeks End of Nippon Merger, CEO Replacement
Jan 27, 2025
04:59 AM EST, 01/27/2025 (MT Newswires) -- US Steel (X) investor Ancora Holdings is pushing the company to stop pursuing a merger with Nippon Steel and has also nominated nine directors to US Steel's board, multiple media outlets reported Sunday, citing sources familiar with the matter. The activist investor is calling for the ouster of US Steel CEO David Burritt...
Copyright 2023-2026 - www.financetom.com All Rights Reserved